UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053739
Receipt number R000061327
Scientific Title Clinical study of ART-A & -SR for patient with recurrent IVF failure, repeated pregnancy losses, and patient who has chromosomal structural rearrangement.
Date of disclosure of the study information 2024/04/01
Last modified on 2024/02/29 18:11:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study of ART-A & -SR for patient with recurrent IVF failure, repeated pregnancy losses, and patient who has chromosomal structural rearrangement.

Acronym

Clinical study of ART-A & -SR

Scientific Title

Clinical study of ART-A & -SR for patient with recurrent IVF failure, repeated pregnancy losses, and patient who has chromosomal structural rearrangement.

Scientific Title:Acronym

Clinical study of ART-A & -SR

Region

Japan


Condition

Condition

repeated ART failure, repeated miscarriage and chromosomal structural rearrangement

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To evaluate efficacy of PGT-A & -STR for patient with recurrent IVF failure, repeated pregnancy losses, and patient who has chromosomal structural rearrangement.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

on-going pregnancy rate at 12th WGA

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Gene

Interventions/Control_1

PGT-A&-SR

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

43 years-old >

Gender

Female

Key inclusion criteria

Recurrent IVF failure
Recurrent pregnancy losses
Chromosomal structural rearrangement

Key exclusion criteria

For PGT-A, patient who has chromosomal structural rearrangement is excluded.
For PGT-SR, patient who has no chromosomal structural rearrangement is excluded.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Masahito
Middle name
Last name Tachibana

Organization

Tohoku university hospital

Division name

Department of obstetrics and gynecology

Zip code

9808574

Address

1-1 Seiryomachi, Aoba-ward, Sendai, Miyagi, 980-8574 Japan

TEL

0227177254

Email

masahito.tachibana.c1@tohoku.ac.jp


Public contact

Name of contact person

1st name Masahito
Middle name
Last name Tachibana

Organization

Tohoku university hospital

Division name

Department of obstetrics and gynecology

Zip code

9808574

Address

1-1 Seiryomachi, Aoba-ward, Sendai, Miyagi, 980-8574 Japan

TEL

0227177254

Homepage URL


Email

masahito.tachibana.c1@tohoku.ac.jp


Sponsor or person

Institute

Tohoku university

Institute

Department

Personal name



Funding Source

Organization

NA

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee Tohoku University Hospital

Address

1-1 Seiryomachi, Aoba-ward,

Tel

227177254

Email

ec@rinri.hosp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 02 Month 29 Day

Date of IRB


Anticipated trial start date

2024 Year 04 Month 01 Day

Last follow-up date

2029 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 02 Month 29 Day

Last modified on

2024 Year 02 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061327